IP Library Granted Patent US 10,456,532
Granted Patent B2
US 10,456,532 · App. 15/026,430 · Granted Oct 29, 2019

Injection device

Inventors: Axel Teucher (Frankfurt am Main, DE); Michael Jugl (Frankfurt am Main, DE)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/3202A61M5/24A61M5/2466A61M5/329A61M5/3293A61M2005/247A61M2005/2474A61M2005/2477
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,456,532
App. No.
15/026,430
Granted
Oct 29, 2019
Kind
B2
Abstract

Described is an injection device ( 1 ) for administering a drug, the injection device ( 1 ) comprising a cartridge holder ( 2 ) adapted to receive a drug cartridge ( 3 ), a hollow injection needle ( 6 ) having a proximal tip ( 6.2 ) adapted to pierce a septum ( 4 ) of the cartridge ( 3 ) so as to establish a fluid communication between the cartridge ( 3 ) and the needle ( 6 ),and a cap ( 7 ) arrangeable over the cartridge holder ( 2 ) in a manner to cover the needle ( 6 ). In an initial state the cartridge ( 3 ) is arranged within the cartridge holder ( 2 ) with the septum ( 4 ) axially spaced from the proximal tip ( 6.2 ) of the needle ( 6 ). The cap ( 7 ) is adapted to move the needle ( 6 ) relative to the septum ( 4 ) for piercing it on movement of the cap ( 7 ) relative to the cartridge holder ( 2 ).

Claims (16)

1. An injection device for administering a drug, the injection device comprising:

a cartridge holder adapted to receive a drug cartridge;

a hollow injection needle having a proximal tip adapted to pierce a septum of the cartridge so as to establish a fluid communication between the cartridge and the needle; and

a cap arrangeable over the cartridge holder in a manner to cover the needle, wherein, in an initial state, the cartridge is arranged within the cartridge holder with the septum axially spaced from the proximal tip of the needle, wherein the cap is adapted to move the needle relative to the septum for piercing the septum on movement of the cap relative to the cartridge holder,

wherein one or more lateral apertures are arranged in the cartridge holder, and the cap comprises one or more internal longitudinal ribs adapted to protrude through the lateral apertures to frictionally clamp and fix the drug cartridge in an axial position within the cartridge holder, and

wherein movement of the cap in a distal direction takes along the cartridge until the cartridge hits a stop within the cartridge holder, wherein continued motion of the cap in the distal direction overcomes friction between the internal longitudinal ribs and the cartridge allowing complete removal of the cap from the cartridge holder.

2. The injection device according to claim 1 , wherein the cap is adapted to move the needle relative to the septum for piercing the septum on movement of the cap relative to the cartridge holder in the distal direction or in a proximal direction or on relative rotational movement of the cap relative to the cartridge holder.

3. The injection device according to claim 1 , wherein the cartridge holder is adapted to allow axial movement of the cartridge within the cartridge holder to and from the needle, wherein the needle is arranged in the cartridge holder.

4. An injection device for administering a drug, the injection device comprising:

a cartridge holder adapted to receive a drug cartridge;

a hollow injection needle having a proximal tip adapted to pierce a septum of the cartridge so as to establish a fluid communication between the cartridge and the needle; and

a cap arrangeable over the cartridge holder in a manner to cover the needle, wherein, in an initial state, the cartridge is arranged within the cartridge holder with the septum axially spaced from the proximal tip of the needle, wherein the cap is adapted to move the needle relative to the septum for piercing the septum on movement of the cap relative to the cartridge holder,

wherein movement of the cap in a distal direction takes along the cartridge until the cartridge hits a stop within the cartridge holder, wherein continued motion of the cap in the distal direction overcomes friction between the cartridge and one or more internal longitudinal ribs of the cap, allowing complete removal of the cap from the cartridge holder.

5. The injection device according to claim 4 , wherein the cap is adapted to move the needle relative to the septum for piercing the septum on movement of the cap relative to the cartridge holder in the distal direction or in a proximal direction or on relative rotational movement of the cap relative to the cartridge holder.

6. The injection device according to claim 4 , wherein the cartridge holder is adapted to allow axial movement of the cartridge within the cartridge holder to and from the needle, wherein the needle is arranged in the cartridge holder.

7. The injection device according to claim 4 , wherein one or more lateral apertures are arranged in the cartridge holder, and the one or more internal longitudinal ribs of the cap are adapted to protrude through the lateral apertures to frictionally clamp and fix the drug cartridge in an axial position within the cartridge holder.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2016
From: TEUCHER, AXEL; JUGL, MICHAEL
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 038852/0409 →
Priority Claims (1)
EP 13189445 · Oct 18, 2013 · regional
Continuity (1)
Related Publication 20160220763A1 · Aug 4, 2016